Abstract
Damage-induced G1 checkpoint in mammalian cells involves upregulation of p53, which activates transcription of p21Waf1 (CDKN1A). Inhibition of cyclin-dependent kinase (CDK)2 and CDK4/6 by p21 leads to dephosphorylation and activation of Rb. We now show that ectopic p21 expression in human HT1080 fibrosarcoma cells causes not only dephosphorylation but also depletion of Rb; this effect was p53-independent and susceptible to a proteasome inhibitor. CDK inhibitor p27 (CDKN1B) also caused Rb dephosphorylation and depletion, but another CDK inhibitor p16 (CDKN2A) induced only dephosphorylation but not depletion of Rb. Rb depletion was observed in both HT1080 and HCT116 colon carcinoma cells, where p21 was induced by DNA-damaging agents. Rb depletion after DNA damage did not occur in the absence of p21, and it was reduced when p21 induction was inhibited by p21-targeting short hairpin RNA or by a transdominant inhibitor of p53. These results indicate that p21 both activates Rb through dephosphorylation and inactivates it through degradation, suggesting negative feedback regulation of damage-induced cell-cycle checkpoint arrest.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Boyer SN, Wazer DE, Band V . (1996). E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin–proteasome pathway. Cancer Res 56: 4620–4624.
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501.
Chang BD, Roninson IB . (1996). Inducible retroviral vectors regulated by lac repressor in mammalian cells. Gene 183: 137–142.
Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB . (2002). Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic drug. Proc Natl Acad Sci USA 99: 389–394.
Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV et al. (2000). Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97: 4291–4296.
Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J et al. (1999). Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18: 4808–4818.
Drexler HC . (1997). Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 94: 855–860.
Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T et al. (2000). Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 6: 96–99.
Jiang H, Chou HS, Zhu L . (1998). Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression. Mol Cell Biol 18: 5284–5290.
Kandel ES, Chang BD, Schott B, Shtil AA, Gudkov AV, Roninson IB . (1997). Applications of green fluorescent protein as a marker of retroviral vectors. Somat Cell Mol Genet 23: 325–340.
Kehn K, Fuente CL, Strouss K, Berro R, Jiang H, Brady J et al. (2005). The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 24: 525–540.
Maliyekkel A, Davis BA, Roninson IB . (2006). Cell cycle arrest drastically extends the duration of gene silencing after transient expression of short hairpin RNA. Cell Cycle 5: 2390–2395.
Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R et al. (1996). Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc Natl Acad Sci USA 93: 10309–10314.
Roninson IB . (2002). Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1–14.
Sdek P, Ying H, Chang DL, Qiu W, Zheng H, Touitou R et al. (2005). MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell 20: 699–708.
Smith ML, Zhan Q, Bae I, Fornace Jr AJ . (1994). Role of retinoblastoma gene product in p53-mediated DNA damage response. Exp Cell Res 215: 386–389.
Stein GH, Drullinger LF, Soulard A, Dulic V . (1999). Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19: 2109–2117.
Tan X, Martin SJ, Green DR, Wang JY . (1997). Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem 272: 9613–9616.
Waldman T, Lengauer C, Kinzler KW, Vogelstein B . (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713–716.
Wiznerowicz M, Trono D . (2003). Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77: 8957–8961.
Ying H, Xiao ZX . (2006). Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 5: 506–508.
Acknowledgements
We thank Dr Bert Vogelstein for HCT116 derivatives, Dr Didier Trono for pLV-tTR-KRAB-red and Natalie Warholic and Jennifer Huntington for technical assistance. This work was supported by NIH grants R01 AG17921, R01 CA62099 and R01 CA95727 (IBR).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Broude, E., Swift, M., Vivo, C. et al. p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation. Oncogene 26, 6954–6958 (2007). https://doi.org/10.1038/sj.onc.1210516
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1210516
Keywords
This article is cited by
-
A RUNX1/ETO-SKP2-CDKN1B axis regulates expression of telomerase in t (8;21) acute myeloid leukemia
Cellular and Molecular Life Sciences (2023)
-
RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines
Scientific Reports (2021)
-
Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer
NPG Asia Materials (2018)
-
Therapeutic effects of histone deacetylase inhibitors on kidney disease
Archives of Pharmacal Research (2018)
-
MiR-139-5p: promising biomarker for cancer
Tumor Biology (2015)


